You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 6,103,219


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,103,219
Title: Pharmaceutical excipient having improved compressibility
Abstract:A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.
Inventor(s): Sherwood; Bob E. (Amenia, NY), Staniforth; John H. (Bath, GB), Hunter; Edward A. (Glenham, NY)
Assignee: Edward Mendell Co., Inc. (Patterson, NY)
Application Number:08/992,073
Patent Claim Types:
see list of patent claims
Composition; Compound; Use; Formulation; Process; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, it is crucial to understand the scope and claims of a patent to ensure its validity and enforceability. This article will delve into the key aspects of patent claims, the importance of proper inventorship, and the challenges associated with result-oriented claims, using U.S. Patent 6,103,219 as a case study.

Understanding Patent Claims

Patent claims are the heart of a patent application, as they define the scope of the invention for which protection is sought. According to U.S. patent law, claims must "particularly point out" and "distinctly claim" the subject matter of the invention[5].

The Structure of Patent Claims

Patent claims typically include independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The clarity and specificity of these claims are critical for determining the patent's scope and validity[5].

Determining Inventorship

Proper inventorship is a vital aspect of patent law. In the United States, the conception of the idea is the key factor in determining who should be listed as an inventor.

Conception and Reduction to Practice

Invention is a two-step process: conception of the idea and reduction to practice. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. Only those who conceived the subject matter of at least one claim of the patent are considered inventors[1].

Collaborative Efforts

In cases where multiple individuals collaborate to produce the invention, all contributors who conceived the subject matter of the claims should be listed as inventors. However, those who merely reduce the invention to practice by exercising ordinary skill in the art are not considered inventors[1].

The Problem with Result-Oriented Claims

Claims that focus solely on achieving a result without detailing the method or process for accomplishing that result often face significant challenges under U.S. patent law.

Eligibility Under 35 U.S.C. § 101

Patent eligibility is governed by 35 U.S.C. § 101, which requires that an invention fit within the categories of a process, machine, manufacture, or composition of matter. However, claims that merely describe the result without offering a specific method or process are often deemed ineligible as they fail to include an inventive concept[2].

Precedential Cases

Cases such as Interval Licensing LLC v. AOL Inc. and American Axle & Manufacturing v. Neapco Holdings LLC illustrate the principle that claims directed to a result without a concrete method are ineligible under § 101. These cases emphasize the need for patent claims to describe the concrete steps or processes required to achieve the claimed result[2].

Drafting Patents with Subjective Claims Terms

When drafting patents, especially those that require subjective terms, it is essential to provide numerous and meaningful examples to ensure clarity.

The Requirement for Clarity

Under 35 USC 112(b), claims must be definite and clear. The courts have recognized the inherent limitations in language but still require a "delicate balance" between these limitations and providing clear notice of what is claimed. The Nautilus v. Biosig Instruments, Inc. case highlights the importance of this balance[5].

Analyzing the Patent Landscape

Understanding the broader patent landscape is crucial for strategic decision-making in patent prosecution and portfolio management.

Patent Analytics Tools

Tools like the Patent 300® Dashboard provide detailed analytics on patent prosecution, portfolio performance, and competitive intelligence. These tools help in identifying key technology areas, gaps in the market, and the performance of law firms and companies in patenting activities[4].

Case Study: U.S. Patent 6,103,219

While the specific details of U.S. Patent 6,103,219 are not provided here, the principles outlined above can be applied to analyze its scope and claims.

Scope of the Claims

To determine the scope of U.S. Patent 6,103,219, one must carefully examine the independent and dependent claims. Each claim should be analyzed to see if it meets the requirements of being definite and clear, and if it includes an inventive concept if it falls under the categories of abstract ideas or natural laws.

Inventorship

The inventors listed on the patent should have conceived the subject matter of at least one claim. Ensuring proper inventorship is crucial to avoid issues of deceptive intent, which can render the patent unenforceable[1].

Result-Oriented Claims

If the claims of U.S. Patent 6,103,219 are result-oriented, they must be scrutinized to ensure they include a specific method or process for achieving the claimed result. Failure to do so could lead to the claims being deemed ineligible under 35 U.S.C. § 101[2].

Key Takeaways

  • Clear and Specific Claims: Patent claims must be clear, definite, and distinctly claim the subject matter of the invention.
  • Proper Inventorship: Only those who conceived the subject matter of the claims should be listed as inventors.
  • Avoid Result-Oriented Claims: Claims must include a specific method or process to achieve the claimed result to be eligible under 35 U.S.C. § 101.
  • Patent Analytics: Utilize tools like the Patent 300® Dashboard to analyze and manage patent portfolios effectively.
  • Subjective Claims Terms: Provide numerous and meaningful examples when using subjective terms in claims to ensure clarity.

FAQs

Q: What is the importance of proper inventorship in U.S. patent law? A: Proper inventorship is crucial as it ensures that only those who conceived the subject matter of the claims are listed as inventors, which is necessary for the patent to be valid and enforceable[1].

Q: Why are result-oriented claims often deemed ineligible under 35 U.S.C. § 101? A: Result-oriented claims are often deemed ineligible because they fail to include a specific method or process for achieving the claimed result, which is required to meet the inventive concept requirement[2].

Q: How can patent analytics tools help in managing a patent portfolio? A: Patent analytics tools like the Patent 300® Dashboard provide detailed insights into patent prosecution, competitive intelligence, and portfolio performance, helping in strategic decision-making and identifying market gaps[4].

Q: What is the significance of the Nautilus v. Biosig Instruments, Inc. case in patent law? A: The Nautilus v. Biosig Instruments, Inc. case emphasizes the need for a "delicate balance" between the inherent limitations of language and providing clear notice of what is claimed, ensuring that claims are definite and clear[5].

Q: How can subjective claims terms be made clearer in patent drafting? A: Subjective claims terms can be made clearer by providing numerous and meaningful examples to illustrate the scope of the invention[5].

Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University[1]
  2. Patently Unclear: Why Result-Oriented Claims Don't Make the Cut Under 35 U.S.C. § 101 - VK Law[2]
  3. Patent Claims Research Dataset - USPTO[3]
  4. Patent 300® Dashboard - Harrity LLP[4]
  5. Practical Advice for Drafting Patents with Subjective Claims Terms - Buchanan Ingersoll & Rooney PC[5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,103,219

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,103,219

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 4759896 ⤷  Try for Free
Australia 5019996 ⤷  Try for Free
Austria 239450 ⤷  Try for Free
Austria 441403 ⤷  Try for Free
Austria 445391 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.